Skip to main content

Table 3 Early and late adverse events

From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry

Variablesa Early (≤6 months) Late (>6 months)
Thromboembolism 1 (0.6) 2 (1.1)
Stroke 0 2 (1.1)
TIA 1 (0.6) 0
Valve thrombosis 0 0
Hemolysis 0 0
Major bleeding 1 (0.6) 0
Non-structural valve dysfunction 0 1 (0.6)
Paravalvular leak   
 Minor 6 (3.4) 6 (3.4)
 Major 1 (0.6) 0
Structural valve deterioration 0 0
Endocarditis 3 (1.7) 2 (1.1)
Prosthesis explant 2 (1.1) 1 (0.6)
Mortality Valve-related 1 (0.6) 0
  1. aCount (Percentage)